Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
LJ Jara, O Vera-Lastra, N Mahroum, C Pineda… - Clinical …, 2022 - Springer
To date, around 60% of the world population has been protected by vaccines against SARS-
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …
[HTML][HTML] IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein
VN Uversky, EM Redwan, W Makis, A Rubio-Casillas - Vaccines, 2023 - mdpi.com
Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
vaccine platform based on mRNA technology was introduced to the market. Globally, around …
[HTML][HTML] Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023
JWC Tervaert, M Martinez-Lavin, LJ Jara, G Halpert… - Autoimmunity …, 2023 - Elsevier
In 2011, a syndrome entitled ASIA (Autoimmune/inflammatory Syndrome Induced by
Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a …
Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a …
[HTML][HTML] Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …
COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: insights from a narrative literature review
Despite their proven efficacy and huge contribution to the health of humankind, vaccines
continue to be a source of concern for some individuals around the world. Vaccinations …
continue to be a source of concern for some individuals around the world. Vaccinations …
Case report: anti-LGI1 encephalitis following COVID-19 vaccination
Anti-leucine rich glioma inactivated 1 (LGI1) autoimmune encephalitis (AE) is characterized
by cognitive impairment or rapid progressive dementia, psychiatric disorders, faciobrachial …
by cognitive impairment or rapid progressive dementia, psychiatric disorders, faciobrachial …
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
Safety of COVID-19 vaccines: spotlight on neurological complications
G Tondo, E Virgilio, A Naldi, A Bianchi, C Comi - Life, 2022 - mdpi.com
The COVID-19 pandemic has led to unprecedented demand on the global healthcare
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
D Gonzalez, L Gupta, V Murthy, EB Gonzalez… - Rheumatology …, 2022 - Springer
Abstract Anti-MDA5 (Melanoma differentiation-associated protein 5) myositis is a rare
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
subtype of dermatomyositis (DM) characterized by distinct ulcerative, erythematous …
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
Bİ Aydoğan, U Ünlütürk, M Cesur - Endocrine, 2022 - Springer
Abstract Purpose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
vaccines have been reported to trigger immune side effects. Type 1 diabetes as a …
vaccines have been reported to trigger immune side effects. Type 1 diabetes as a …